Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB)

D. M. Cirillo, F. Piana, L. Frisicale, M. Quaranta, A. Riccabone, V. Penati, P. Vaccarino, G. Marchiaro

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

M. tuberculosis is one of the leading causes of death worldwide and Multi Drug Resistant Tuberculosis (MDR-TB) is associated with a high case-fatality rate. Rapid identification of resistant strains is crucial to institute prompt appropriate therapy, and prevent the development of further resistance and spreading of MDR strains. The INNO-LiPA Rif. TB is a commercial reverse hybridisation line probe assay designed for rapid detection of rpoB gene mutations in clinical isolates. We applied this test directly to 44 smear-positive and 45 smear-negative clinical specimens collected from patients suspected of active TB. The capability of this technique to correctly identify local MDR-TB strains was tested on 50 MDR strains isolated in Italy. Results of the test were compared to conventional antibiogram performed on isolated strains. The concordance rate of the LiPA test results on clinical specimens with those obtained with "in vitro" sensitivity was 100%. These results show that the LiPA test can be useful in rapid detection and prompt management of tuberculosis when MDR disease is suspected.

Original languageEnglish
Pages (from-to)221-227
Number of pages7
JournalNew Microbiologica
Volume27
Issue number3
Publication statusPublished - Jul 2004

Fingerprint

Multidrug-Resistant Tuberculosis
Rifampin
Tuberculosis
Infection
Microbial Sensitivity Tests
Italy
Cause of Death
Mutation
Mortality
Genes
Therapeutics

Keywords

  • LiPA assay
  • M. tuberculosis
  • Rifampicin resistance

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Cirillo, D. M., Piana, F., Frisicale, L., Quaranta, M., Riccabone, A., Penati, V., ... Marchiaro, G. (2004). Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiologica, 27(3), 221-227.

Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). / Cirillo, D. M.; Piana, F.; Frisicale, L.; Quaranta, M.; Riccabone, A.; Penati, V.; Vaccarino, P.; Marchiaro, G.

In: New Microbiologica, Vol. 27, No. 3, 07.2004, p. 221-227.

Research output: Contribution to journalArticle

Cirillo, DM, Piana, F, Frisicale, L, Quaranta, M, Riccabone, A, Penati, V, Vaccarino, P & Marchiaro, G 2004, 'Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB)', New Microbiologica, vol. 27, no. 3, pp. 221-227.
Cirillo, D. M. ; Piana, F. ; Frisicale, L. ; Quaranta, M. ; Riccabone, A. ; Penati, V. ; Vaccarino, P. ; Marchiaro, G. / Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). In: New Microbiologica. 2004 ; Vol. 27, No. 3. pp. 221-227.
@article{6f7ee0702066434fa77150ec32647273,
title = "Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB)",
abstract = "M. tuberculosis is one of the leading causes of death worldwide and Multi Drug Resistant Tuberculosis (MDR-TB) is associated with a high case-fatality rate. Rapid identification of resistant strains is crucial to institute prompt appropriate therapy, and prevent the development of further resistance and spreading of MDR strains. The INNO-LiPA Rif. TB is a commercial reverse hybridisation line probe assay designed for rapid detection of rpoB gene mutations in clinical isolates. We applied this test directly to 44 smear-positive and 45 smear-negative clinical specimens collected from patients suspected of active TB. The capability of this technique to correctly identify local MDR-TB strains was tested on 50 MDR strains isolated in Italy. Results of the test were compared to conventional antibiogram performed on isolated strains. The concordance rate of the LiPA test results on clinical specimens with those obtained with {"}in vitro{"} sensitivity was 100{\%}. These results show that the LiPA test can be useful in rapid detection and prompt management of tuberculosis when MDR disease is suspected.",
keywords = "LiPA assay, M. tuberculosis, Rifampicin resistance",
author = "Cirillo, {D. M.} and F. Piana and L. Frisicale and M. Quaranta and A. Riccabone and V. Penati and P. Vaccarino and G. Marchiaro",
year = "2004",
month = "7",
language = "English",
volume = "27",
pages = "221--227",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "3",

}

TY - JOUR

T1 - Direct rapid diagnosis of rifampicin-resistant M. Tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB)

AU - Cirillo, D. M.

AU - Piana, F.

AU - Frisicale, L.

AU - Quaranta, M.

AU - Riccabone, A.

AU - Penati, V.

AU - Vaccarino, P.

AU - Marchiaro, G.

PY - 2004/7

Y1 - 2004/7

N2 - M. tuberculosis is one of the leading causes of death worldwide and Multi Drug Resistant Tuberculosis (MDR-TB) is associated with a high case-fatality rate. Rapid identification of resistant strains is crucial to institute prompt appropriate therapy, and prevent the development of further resistance and spreading of MDR strains. The INNO-LiPA Rif. TB is a commercial reverse hybridisation line probe assay designed for rapid detection of rpoB gene mutations in clinical isolates. We applied this test directly to 44 smear-positive and 45 smear-negative clinical specimens collected from patients suspected of active TB. The capability of this technique to correctly identify local MDR-TB strains was tested on 50 MDR strains isolated in Italy. Results of the test were compared to conventional antibiogram performed on isolated strains. The concordance rate of the LiPA test results on clinical specimens with those obtained with "in vitro" sensitivity was 100%. These results show that the LiPA test can be useful in rapid detection and prompt management of tuberculosis when MDR disease is suspected.

AB - M. tuberculosis is one of the leading causes of death worldwide and Multi Drug Resistant Tuberculosis (MDR-TB) is associated with a high case-fatality rate. Rapid identification of resistant strains is crucial to institute prompt appropriate therapy, and prevent the development of further resistance and spreading of MDR strains. The INNO-LiPA Rif. TB is a commercial reverse hybridisation line probe assay designed for rapid detection of rpoB gene mutations in clinical isolates. We applied this test directly to 44 smear-positive and 45 smear-negative clinical specimens collected from patients suspected of active TB. The capability of this technique to correctly identify local MDR-TB strains was tested on 50 MDR strains isolated in Italy. Results of the test were compared to conventional antibiogram performed on isolated strains. The concordance rate of the LiPA test results on clinical specimens with those obtained with "in vitro" sensitivity was 100%. These results show that the LiPA test can be useful in rapid detection and prompt management of tuberculosis when MDR disease is suspected.

KW - LiPA assay

KW - M. tuberculosis

KW - Rifampicin resistance

UR - http://www.scopus.com/inward/record.url?scp=11844250634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844250634&partnerID=8YFLogxK

M3 - Article

C2 - 15460524

AN - SCOPUS:11844250634

VL - 27

SP - 221

EP - 227

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 3

ER -